Analysts think AEMD stock price could increase by 891%
Jun 14, 2024, 6:28 AM
-17.41%
What does AEMD do
Aethlon Medical Inc., based in San Diego, develops the Hemopurifier, a device for treating advanced cancer and various life-threatening viruses including HIV, HCV, and Ebola. The device works by removing tumor-derived exosomes and virus glycoproteins to reduce immune suppression and disease progression.
4 analysts think AEMD stock price will increase by 891.22%. The current median analyst target is $6.88 compared to a current stock price of $0.69. The lowest analysts target is $3.54 and the highest analyst target is $10.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.